Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy (Biocells Medical)

N/A

Report date: 2026/03/16 20:01:47

Base Information

Drug NameAllogeneic Mesenchymal Stem Cell-Derived Exosome Therapy (Biocells Medical)
Drug Alias NameN/A
ClassificationBiologics > Exosomes > Stem cell-derived exosomes
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSpinocerebellar AtaxiasParkinsonian DisordersMultiple System Atrophy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiocells Medical
China Registration ClassN/A

Develop Information

Active CompaniesBiocells Medical
Inactive CompaniesN/A
Active IndicationsSpinocerebellar AtaxiasParkinsonian DisordersMultiple System Atrophy
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A